MEDNAX, Inc., (NYSE:MD) announced today that it is scheduled to make a presentation to investors attending the Thomas Weisel Partners Annual Healthcare conference in Boston, MA on Wednesday, September 9, at 4:25 p.m. Eastern Time.
The presentation will be made by MEDNAX’s Director of Investor Relations, Bob Kneeley, and will be broadcast through a live audio Webcast and will be available for replay at www.mednax.com.
About MEDNAX
MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,300 physicians in 32 states and Puerto Rico. Additional information is available at www.mednax.com.
Contacts:
MEDNAX, Inc.
Bob Kneeley, Director, Investor Relations,
954-384-0175, x-5300
bob_kneeley@mednax.com
